Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
COLO 858 | Vemurafenib | Defactinib | 1.000 | 0.316 | uM | 72 | hr | 2 | 1493 | 1144 | 0.0414 | 0.0451 | 0.7662 | 0.7585 |
COLO 858 | Vemurafenib | Defactinib | 1.000 | 0.316 | uM | 72 | hr | 3 | 1675 | 1292 | 0.0455 | 0.0451 | 0.7713 | 0.7585 |
COLO 858 | Vemurafenib | Defactinib | 1.000 | 1.000 | uM | 72 | hr | 1 | 1205 | 991 | 0.0254 | 0.0294 | 0.8224 | 0.8047 |
COLO 858 | Vemurafenib | Defactinib | 1.000 | 1.000 | uM | 72 | hr | 2 | 1294 | 999 | 0.0350 | 0.0294 | 0.7720 | 0.8047 |
COLO 858 | Vemurafenib | Defactinib | 1.000 | 1.000 | uM | 72 | hr | 3 | 1293 | 1060 | 0.0277 | 0.0294 | 0.8198 | 0.8047 |
COLO 858 | Vemurafenib | Defactinib | 1.000 | 3.160 | uM | 72 | hr | 1 | 933 | 827 | 0.0126 | 0.0137 | 0.8864 | 0.8777 |
COLO 858 | Vemurafenib | Defactinib | 1.000 | 3.160 | uM | 72 | hr | 2 | 1025 | 897 | 0.0152 | 0.0137 | 0.8751 | 0.8777 |
COLO 858 | Vemurafenib | Defactinib | 1.000 | 3.160 | uM | 72 | hr | 3 | 864 | 753 | 0.0132 | 0.0137 | 0.8715 | 0.8777 |
COLO 858 | Vemurafenib | Defactinib | 3.160 | 0.000 | uM | 72 | hr | 1 | 1712 | 1553 | 0.0189 | 0.0193 | 0.9071 | 0.9069 |
COLO 858 | Vemurafenib | Defactinib | 3.160 | 0.000 | uM | 72 | hr | 2 | 1727 | 1557 | 0.0202 | 0.0193 | 0.9016 | 0.9069 |
COLO 858 | Vemurafenib | Defactinib | 3.160 | 0.000 | uM | 72 | hr | 3 | 1810 | 1651 | 0.0189 | 0.0193 | 0.9122 | 0.9069 |
COLO 858 | Vemurafenib | Defactinib | 3.160 | 0.316 | uM | 72 | hr | 1 | 1556 | 1484 | 0.0085 | 0.0082 | 0.9537 | 0.9545 |
COLO 858 | Vemurafenib | Defactinib | 3.160 | 0.316 | uM | 72 | hr | 2 | 1479 | 1417 | 0.0074 | 0.0082 | 0.9581 | 0.9545 |
COLO 858 | Vemurafenib | Defactinib | 3.160 | 0.316 | uM | 72 | hr | 3 | 1488 | 1416 | 0.0085 | 0.0082 | 0.9516 | 0.9545 |
COLO 858 | Vemurafenib | Defactinib | 3.160 | 1.000 | uM | 72 | hr | 1 | 1509 | 1433 | 0.0090 | 0.0077 | 0.9496 | 0.9513 |
COLO 858 | Vemurafenib | Defactinib | 3.160 | 1.000 | uM | 72 | hr | 2 | 1444 | 1385 | 0.0070 | 0.0077 | 0.9591 | 0.9513 |
COLO 858 | Vemurafenib | Defactinib | 3.160 | 1.000 | uM | 72 | hr | 3 | 1094 | 1034 | 0.0071 | 0.0077 | 0.9452 | 0.9513 |
COLO 858 | Vemurafenib | Defactinib | 3.160 | 3.160 | uM | 72 | hr | 1 | 921 | 884 | 0.0044 | 0.0047 | 0.9598 | 0.9535 |
COLO 858 | Vemurafenib | Defactinib | 3.160 | 3.160 | uM | 72 | hr | 2 | 809 | 781 | 0.0033 | 0.0047 | 0.9654 | 0.9535 |
COLO 858 | Vemurafenib | Defactinib | 3.160 | 3.160 | uM | 72 | hr | 3 | 850 | 795 | 0.0065 | 0.0047 | 0.9353 | 0.9535 |
COLO 858 | Vemurafenib | JNK-IN-8 | 0.000 | 0.000 | uM | 72 | hr | 1 | 7080 | 1047 | 1.0004 | 1.0000 | 0.1479 | 0.1426 |
COLO 858 | Vemurafenib | JNK-IN-8 | 0.000 | 0.000 | uM | 72 | hr | 2 | 7642 | 1063 | 1.0910 | 1.0000 | 0.1391 | 0.1426 |
COLO 858 | Vemurafenib | JNK-IN-8 | 0.000 | 0.000 | uM | 72 | hr | 3 | 6377 | 898 | 0.9086 | 1.0000 | 0.1408 | 0.1426 |
COLO 858 | Vemurafenib | JNK-IN-8 | 0.000 | 0.316 | uM | 72 | hr | 1 | 5588 | 784 | 0.7966 | 0.8682 | 0.1403 | 0.1425 |
COLO 858 | Vemurafenib | JNK-IN-8 | 0.000 | 0.316 | uM | 72 | hr | 2 | 6063 | 889 | 0.8580 | 0.8682 | 0.1466 | 0.1425 |